Cutaneous Fungal and Viral Infections in Athletes

Clinics in Sports Medicine

Volumn 26, Issue 3, 2007, Pages 397-411

  Pleacher, Michael D ^a   Dexter, William W ^b  

^a McKay Dee Dermatology   (United States)

^b MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLYLAMINE DERIVATIVE; ANTIVIRUS AGENT; BLEOMYCIN; CANTHARIDIN; CLOTRIMAZOLE; FAMCICLOVIR; FLUCONAZOLE; FLUOROURACIL; GRISEOFULVIN; IMIDAZOLE DERIVATIVE; IMIQUIMOD; ITRACONAZOLE; KETOCONAZOLE; NAFTIFINE; PLACEBO; PYRROLE DERIVATIVE; RETINOID DERIVATIVE; SALICYLIC ACID; SILVER NITRATE; TERBINAFINE; TRICHLOROACETIC ACID; VALACICLOVIR;

ABSENCE OF SIDE EFFECTS; AMINOTRANSFERASE BLOOD LEVEL; CLINICAL FEATURE; CLINICAL TRIAL; CRYOSURGERY; CURETTAGE; DERMATOPHYTE; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG INDUCED HEADACHE; DYSPEPSIA; FLATULENCE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HERPES SIMPLEX; HUMAN; HYPERKERATOSIS; LEUKOPENIA; MOLLUSCUM CONTAGIOSUM; MYCOSIS; PARESTHESIA; PATHOPHYSIOLOGY; PHOTOSENSITIVITY; PRURITUS; REVIEW; SIDE EFFECT; SKIN INFECTION; TINEA CAPITIS; TINEA CORPORIS; TINEA CRURIS; TINEA GLADIATORUM; TINEA PEDIS; VERRUCA VULGARIS; VIRUS INFECTION;

ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; DERMATOMYCOSES; HUMANS; MORBIDITY; PROGNOSIS; SKIN DISEASES, VIRAL; SPORTS; WORLD HEALTH;

EID: 34548449289     PISSN: 02785919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.csm.2007.04.004     Document Type: Review

References (54)

1. Murphy G.F., and Mihm Jr. M.C. The skin. In: Cotran R.S., Kumar V., and Collins T. (Eds). Robbins pathologic basis of disease. 6th edition (1999), WB Saunders, Philadelphia 1170-1213
2. In: Fitzpatrick T.B., Johnson R.A., Wolff K., et al. (Eds). Cutaneous fungal infections . Color atlas and synopsis of clinical dermatology. 3rd edition (1997), McGraw-Hill, New York 688-733
3. Odom R. Pathophysiology of dermatophyte infections. J Am Acad Dermatol 28 (1993) S2-S7
4. Drake L.A., Dinehart S.M., Farmer E.R., et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. J Am Acad Dermatol 34 2 pt 1 (1996) 282-286
5. Taylor S.C. Epidemiology of skin diseases in ethnic populations. Dermatol Clin 21 (2003) 601-607
6. Adams B.B. Tinea corporis gladiatorum. J Am Acad Dermatol 47 (2002) 286-290
7. Gupta A.K., Chaudhry M., and Elewski B. Tinea corporis, tinea cruris, tinea nigra, and piedra. Dermatol Clin 21 (2003) 395-400
8. Gupta A.K., Cooper E.A., Ryder J.E., et al. Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol 5 (2004) 225-237
9. Winokur R.C., and Dexter W.W. Fungal infections and parasitic infections in sports. Phys Sports Med 32 (2004) 23-33
10. Budimulja U., Bramono K., Urip K.S., et al. Once daily treatment with terbinafine 1% cream for one week is effective in the treatment of tinea corporis and cruris: a placebo controlled study. Mycoses 44 (2001) 300-306
11. Lester M. Ketoconazole 2 percent cream in the treatment of tinea pedis, tinea cruris, and tinea corporis. Cutis 55 (1995) 181-183
12. Faergemann J., Mork N.J., Haglund A., et al. A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. Br J Dermatol 136 (1997) 575-577
13. Pariser D.M., Pariser R.J., Ruoff G., et al. Double-blind comparison of itraconazole and placebo in the treatment of tinea corporis and tinea cruris. J Am Acad Dermatol 31 (1994) 232-234
14. Farag A., Taha M., and Halim S. One-week therapy with oral terbinafine in cases of tinea cruris/corporis. Br J Dermatol 131 (1994) 684-686
15. Stary A., and Sarnow E. Fluconazole in the treatment of tinea corporis and tinea cruris. Dermatology 196 (1998) 237-241
16. Crawfod F., Hart R., Bell-Syer S., et al. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev 2 (2000) CD001434
17. Bell-Syer S.E.M., Hart R., Crawford F., et al. Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev 2 (2002) CD003584
18. Kohl T.D., and Lisney M. Tinea gladiatorum: wrestling's emerging foe. Sports Med 29 (2000) 439-447
19. Foster K.W., Ghannoum M.A., and Elewski B.E. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol 50 (2004) 748-752
20. Stiller M.J., Klein W.P., Dorman R.I., et al. Tinea corporis gladiatorum: an epidemic of Trichophyton tonsurans in student wrestlers. J Am Acad Dermatol 27 (1992) 632-633
21. Beller M., and Gessner B.D. An outbreak of tinea corporis gladiatorum on a high school wrestling team. J Am Acad Dermatol 31 (1994) 197-201
22. Hradil E., Hersle K., Nordin P., et al. An epidemic of tinea corporis caused by Trychophyton tonsurans among wrestlers in Sweden. Acta Derm Venereol (Stockh) 75 (1995) 305-306
23. Pique E., Copado R., Cabrera A., et al. An outbreak of tinea gladiatorum in Lanzarote. Clin Exp Dermatol 24 (1999) 7-9
24. Adams B.B. Tinea corporis gladiatorum: a cross-sectional study. J Am Acad Dermatol 43 (2000) 1039-1041
25. Kohl T.D., Giesen D.P., Moyer Jr. J., et al. Tinea gladiatorum: Pennsylvania's experience. Clin J Sport Med 12 (2002) 165-171
26. Kohl T.D., Martin D.C., and Berger M.S. Comparison of topical and oral treatments for tinea gladiatorum. Clin J Sport Med 9 (1999) 161-166
27. Kohl T.D., Martin D.C., Nemeth R., et al. Fluconazole for the prevention and treatment of tinea gladiatorum. Pediatr Infect Dis J 19 (2000) 717-722
28. NCAA Rules Committee. "Appendix D: Skin Infections" in wrestling: 2006 rules and interpretations, 2005. Available at: http://www2.ncaa.org/media_and_events/ncaa_publications/playing_rules/. Accessed November 30, 2005.
29. National Federation of State High School Associations, Sports Medicine Advisory Committee. Physician release for wrestler to participate with skin lesion. Available at: http://www.nfhs.org. Accessed March 15, 2006.
30. Caputo R., De Boulle K., Del Rosso J., et al. Prevalence of superficial fungal infections among sports-active individuals: results from the Achilles survey, a review of the literature. J Eur Acad Dermatol Venereol 15 (2001) 312-316
31. Kamihama T., Kimura T., Hosokawa J.-I., et al. Tinea pedis outbreak in swimming pools in Japan. Public Health 111 (1997) 249-253
32. Auger P., Marquis G., Joly J., et al. Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete's foot. Mycoses 36 (1993) 35-41
33. Lacroix C., Baspeyras M., de La Salmoniere P., et al. Tinea pedis in European marathon runners. J Eur Acad Dermatol Venereol 16 (2002) 139-142
34. Strauss R.H., Leizman D.J., Lanese R.R., et al. Abrasive shirts may contribute to herpes gladiatorum among wrestlers. N Engl J Med 320 (1989) 598-599
35. Wheeler C.E., and Cabaniss W.H. Epidemic cutaneous herpes simplex in wrestlers (herpes gladiatorum). JAMA 194 (1965) 145-149
36. Keilhofner M., and McKinsey D.S. Herpes gladiatorum in a high school wrestler. Mo Med 85 (1988) 723-725
37. Rosenbaum G.S., Strampfer M.J., and Cunha B.A. Herpes gladiatorum in a male wrestler. Int J Dermatol 29 (1990) 141-142
38. US Department of Health and Human Services, Public Health Service. Herpes gladiatorum at a high school wrestling camp-Minnesota. MMWR Morb Mortal Wkly Rep 39 (1990) 69-71
39. Belongia E.A., Goodman J.L., Holland E.J., et al. An outbreak of herpes gladiatorum at a high school wrestling camp. N Engl J Med 325 (1991) 906-910
40. Holland E.J., Mahanti R.L., Belongia E.A., et al. Ocular involvement in an outbreak of herpes gladiatorum. Am J Ophthalmol 114 (1992) 680-684
41. Becker T.M., Kodsi R., Bailey P., et al. Grappling with herpes: herpes gladiatorum. Am J Sports Med 16 (1988) 665-669
42. Anderson B.J. The epidemiology and clinical analysis of several outbreaks of herpes gladiatorum. Med Sci Sports Exerc 11 (2003) 1809-1814
43. Barton S.E., Ebel C.W., Kirchner J.T., et al. The clinical management of recurrent genital herpes: current issues and future prospects. Herpes 9 (2002) 15-20
44. Tyring S.K., Douglas Jr. J.M., Corey L., et al. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. Arch Dermatol 134 (1998) 185-191
45. Anderson B.J. Valacyclovir to expedite the clearance of recurrent herpes gladiatorum. Clin J Sport Med 15 (2005) 364-366
46. Anderson B.J. The effectiveness of valacyclovir in preventing reactivation of herpes gladiatorum in wrestlers. Clin J Sport Med 9 (1999) 86-90
47. Niizeki K., and Hashimoto K. Treatment of molluscum contagiosum with silver nitrate paste. Pediatr Dermatol 16 (1999) 395-397
48. Theos A.U., Cummins R., Silverberg N.B., et al. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis 74 (2004) 134-142
49. Syed T.A., Goswami J., Ahmadpour O.A., et al. Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study. J Dermatol 25 (1998) 309-313
50. Massing A.M., and Epstein W.L. Natural history of warts. A two-year study. Arch Dermatol 87 (1963) 306-310
51. Gibbs S., Harvey I., Sterling J., et al. Local treatments for cutaneous warts: systematic review. BMJ 325 (2002) 461-467
52. Grussendorf-Conen E.I., and Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol 19 (2002) 263-266
53. Grussendorf-Conen E.I., Jacobs S., Rubben A., et al. Topical 5% imiquimod long-term treatment of cutaneous warts resistant to standard therapy modalities. Dermatology 205 (2002) 139-145
54. Hengge U.R., Esser S., Schultewolter T., et al. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol 143 (2000) 1026-1031